Vlad T
No ORCID on file
· 1 paper in corpus
2025
Background/Objectives: Aromatase inhibitors (AIs)-specifically, letrozole, anastrozole and exemestane-represent the current gold standard for patients with estrogen-receptor-positive breast cancer (ER + BC). This narrative review highlights…